Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,975 | 97,804 | 51,405 | 75,838 | 48,274 |
| Marketable Securities | 184,719 | 138,207 | 71,407 | 152,498 | 180,750 |
| Receivables | 460 | 558 | 104 | 1,918 | 4,385 |
| TOTAL | $214,359 | $240,111 | $125,557 | $235,933 | $240,342 |
| Non-Current Assets | |||||
| PPE Net | 18,045 | 18,983 | 19,799 | 18,792 | 14,206 |
| Investments And Advances | 230,154 | 212,484 | 142,164 | 67,482 | 63,741 |
| Intangibles | 0 | 0 | 0 | 145 | 188 |
| TOTAL | $248,199 | $231,467 | $161,963 | $86,419 | $78,135 |
| Total Assets | $462,558 | $471,578 | $287,520 | $322,352 | $318,477 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,534 | 3,105 | 4,420 | 5,093 | 5,519 |
| Accrued Expenses | 13,720 | 12,109 | 11,558 | 14,914 | 14,228 |
| Other current liabilities | N/A | N/A | N/A | 2,755 | 1,364 |
| TOTAL | $53,066 | $49,750 | $48,345 | $54,758 | $57,064 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 34,812 | 34,536 | 32,367 | 31,996 | 35,953 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 521 | 690 |
| TOTAL | $101,317 | $110,272 | $105,122 | $90,434 | $73,126 |
| Total Liabilities | $154,383 | $160,022 | $153,467 | $145,192 | $130,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,960 | 62,171 | 61,867 | 52,414 | 52,245 |
| Common Shares | 624 | 621 | 525 | 524 | 520 |
| Retained earnings | -534,192 | -516,023 | -507,010 | -444,822 | -425,320 |
| Other shareholders' equity | 28,130 | 20,821 | 15,662 | 108 | -62 |
| TOTAL | $308,175 | $311,556 | $134,053 | $177,160 | $188,287 |
| Total Liabilities And Equity | $462,558 | $471,578 | $287,520 | $322,352 | $318,477 |